Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in 3 phase III North American studies

被引：0
|
作者：
Curry, Michael [1 ]
Vargas, Hugo E. [2 ]
Befeler, Alex [3 ]
Pyrsopoulos, Nikolaos T. [4 ]
Patwardhan, Vilas [1 ]
Jamil, Khurram [5 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Mayo Clin, Rochester, MN USA
[3] St Louis Univ, St Louis, MO USA
[4] Rutgers New Jersey Med Sch, Univ Hosp, Newark, NJ USA
[5] Mallinckrodt Pharmaceut, Staines Upon Thames, England
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI537
引用
收藏
页码：S634 / S635
页数：2
相关论文
共 50 条
  • [21] TERLIPRESSIN GIVEN BY CONTINUOUS INTRAVENOUS INFUSION VS TERLIPRESSIN GIVEN BY INTRAVENOUS BOLUSES IN THE TREATMENT OF HEPATORENAL SYNDROME IN PATIENTS WITH CIRRHOSIS: FINAL RESULTS OF A CONTROLLED CLINICAL STUDY
    Cavallin, M.
    Piano, S.
    Fasolato, S.
    Frigo, A. C.
    Benetti, G. P.
    Romano, A.
    Morando, F.
    Pilutti, C.
    Rosi, S.
    Tonon, M.
    Stanco, M. L.
    Gola, E.
    Sticca, A.
    Cillo, U.
    Gatta, A.
    Angeli, P.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E15 - E15
  • [22] Terlipressin given by continuous intravenous infusion versus terlipressin given by intravenous boluses in the treatment of hepatorenal syndrome in patients with cirrhosis: final results of a controlled clinical study
    Cavallin, Marta
    Piano, Salvatore
    Fasolato, Silvano
    Frigo, Anna Chiara
    Benetti, Gianpiero
    Romano, Antonietta
    Morando, Filippo
    Pilutti, Chiara
    Rosi, Silvia
    Tonon, Marta
    Stanco, Marialuisa
    Gola, Elisabetta
    Sticca, Antonietta
    Cillo, Umberto
    Gatta, Angelo
    Angeli, Paolo
    HEPATOLOGY, 2015, 62 : 284A - 284A
  • [23] THE CONFIRM STUDY: A NORTH AMERICAN RANDOMIZED CONTROLLED TRIAL (RCT) OF TERLIPRESSIN PLUS ALBUMIN FOR THE TREATMENT OF HEPATORENAL SYNDROME TYPE 1 (HRS-1)
    Wong, Florence
    Curry, Michael P.
    Reddy, K. Rajender
    Rubin, Raymond A.
    Porayko, Michael K.
    Gonzalez, Stevan A.
    Mumtaz, Khalid
    Lim, Nicholas
    Simonetto, Douglas A.
    Sharma, Pratima
    Sanyal, Arun J.
    Mayo, Marlyn J.
    Frederick, Richard Todd
    Pappas, Stephen Chris
    Jamil, Khurram
    HEPATOLOGY, 2019, 70 (06) : 1480A - 1481A
  • [24] THE IMPACT OF MELD SCORE AND ACLF GRADE ON OUTCOMES OF HEPATORENAL SYNDROME FOLLOWING TREATMENT WITH TERLIPRESSIN AND ALBUMIN IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS
    Weinberg, Ethan M.
    Jamil, Khurram
    Deng, Richard
    Reddy, K. Rajender Rajender
    HEPATOLOGY, 2023, 78 : S1365 - S1366
  • [25] Defining Renal Recovery in Patients With Hepatorenal Syndrome-Acute Kidney Injury: Experience From North American Studies
    Mujtaba, Muhammad A.
    Elsiesy, Hussien
    Faiz, Sara
    Hussain, Syed A.
    Gamilla-Crudo, Ann Kathleen N.
    Karim, Aftab
    Khan, Mohammad Irfan
    Khattak, Muhammad Waqar
    Zafar, Zunaira
    Kueht, Michael
    Jamil, Khurram
    JGH OPEN, 2024, 8 (12):
  • [26] PATIENT SUBSET ANALYSIS OF THE REVERSE PHASE I I I STUDY: THE IMPACT OF TERLIPRESSIN TREATMENT ON RATES OF TRANSPLANT, DIALYSIS, AND SURVIVAL IN PATIENTS WITH HEPATORENAL SYNDROME
    Sigal, Samuel H.
    Sanyal, Arun
    Wong, Mark
    McGuire, Brendan M.
    Hameed, Bilal
    Jamil, Khurram
    HEPATOLOGY, 2023, 78 : S1346 - S1348
  • [27] Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies
    David L. Paterson
    Masahiro Kinoshita
    Takamichi Baba
    Roger Echols
    Simon Portsmouth
    Infectious Diseases and Therapy, 2022, 11 : 853 - 870
  • [28] Outcomes with Cefiderocol Treatment in Patients with Bacteraemia Enrolled into Prospective Phase 2 and Phase 3 Randomised Clinical Studies
    Paterson, David L.
    Kinoshita, Masahiro
    Baba, Takamichi
    Echols, Roger
    Portsmouth, Simon
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 853 - 870
  • [29] TERLIPRESSIN GIVEN AS CONTINUOUS INTRAVENOUS INFUSION IS THE MORE SUITABLE SCHEDULE FOR THE TREATMENT OF TYPE 1 HEPATORENAL SYNDROME (HRS) IN PATIENTS WITH CIRRHOSIS: RESULTS OF A CONTROLLED CLINICAL STUDY
    Angeli, Paolo
    Fasolato, Silvana
    Cavallin, Marta
    Maresio, Giulio
    Callegaro, Alessia
    Sticca, Antonietta
    Mazza, Elena
    Benetti, Gianpiero
    Gatta, Angelo
    HEPATOLOGY, 2008, 48 (04) : 378A - 378A
  • [30] TERLIPRESSIN AND ALBUMIN VS MIDODRINE PLUS OCTREOTIDE AND ALBUMIN IN THE TREATMENT OF HEPATORENAL SYNDROME IN PATIENTS WITH CIRRHOSIS: RESULTS OF A CONTROLLED CLINICAL TRIAL BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER
    Cavallin, Marta
    Merli, Manuela
    Fasolato, Silvano
    Toniutto, Pierluigi
    Salerno, Francesco
    Bernardi, Mauro
    Colletta, Cosimo
    Salinas, Freddy
    Digiacomo, Antonio
    Ridola, Lorenzo
    Fornasiere, Ezio
    Cazzaniga, Massimo
    Caraceni, Paolo
    Gatta, Angelo
    Angeli, Paolo
    HEPATOLOGY, 2011, 54 : 1426A - 1427A
12345